Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 20-1 (TRBV20-1) encodes the variable region of the beta chain of the T cell receptor (TCR), a critical component of the immune system. The TCR is a heterodimeric protein complex usually comprising an alpha and a beta chain, both of which are highly variable due to V(D)J recombination, enabling recognition of a vast repertoire of antigens presented by the major histocompatibility complex (MHC) on antigen presenting cells. TRBV20-1 is one of the most commonly used variable gene segments in human T cell populations and is part of the TCR complex on T lymphocytes that mediates antigen-specific recognition, leading to immune cell activation, signaling via the CD3 complex, and downstream pathways including MAPK and NF-κB activation. TRBV20-1 is frequently observed in both normal and malignant T cell repertoires and has been used as a molecular marker to study T cell clonality in cancer and infectious diseases[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 20-1 (TRBV20-1).